Entering text into the input field will update the search result below

Neurodiagnostics Market Development And Business Intelligence

Jan. 29, 2021 4:59 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Market Growth Factors & Global Market Size.
  • Leading Players & Top Segments.
  • Geographic Overview.

Market growth influenced due to following factors-

  • Increasing prevalence of neurological disorders & diseases,
  • Technological advancements,
  • Growing patient emphasis on effective & early disease diagnosis,
  • The growing number of diagnostic centers & hospitals,
  • Use of biomarker profiling for disease diagnostics. 

Global market size-

According to the research report neurodiagnostics market is expected to reach $8.4 billion by 2024 from $5.9 billion in 2019, at a CAGR of 7.3%.

Leading Players-

Some of the prominent players in the Neurodiagnostics market include GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).

Top Market Segments-

Based on the product, the neurodiagnostics market is segmented into diagnostic imaging systems, clinical diagnostic instruments, and reagents and consumables. The diagnostic imaging systems segment accounted for the largest share of the neurodiagnostics technology market in 2018. The increasing incidence and prevalence of neurological disorders and growing R&D in the field of cerebral and spinal disorders are the major factors driving the growth of this segment 

On the basis of end-user, the neurodiagnostics market is segmented into hospitals & surgical centers, diagnostic laboratories & imaging centers, neurology centers, ambulatory care centers (OTCPK:ACCS), and research laboratories & academic institutes.

For Details, Download PDF Brochure Here

Geographic Overview -

North America accounted for the largest share of the Neurodiagnostic Market, by region, in 2018, followed by Europe. This can primarily be attributed to factors such as the high adoption of innovative neurodiagnostic devices among medical professionals, and full availability of advanced neurodiagnostic devices.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.